{
 "Susceptible": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 37.93103, 62.06897 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 62.06897, 37.93103 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 93.10345, 6.896552 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Amoxycillin clavulanate": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 36.36364, 63.63636 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 81.81818, 18.18182 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 81.81818, 18.18182 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Aztreonam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       44,       56 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       60,       40 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [       92,        8 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 45.45455, 54.54545 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 63.63636, 36.36364 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 90.90909, 9.090909 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftaroline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 77.77778, 22.22222 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 88.88889, 11.11111 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 42.85714, 57.14286 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 90.47619,  9.52381 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime avibactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [   40.625,   59.375 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [   59.375,   40.625 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [    93.75,     6.25 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftolozane tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       44,       56 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       60,       40 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [       92,        8 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       45,       55 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       70,       30 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [       90,       10 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Doripenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 36.66667, 63.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       60,       40 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 93.33333, 6.666667 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Imipenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 37.93103, 62.06897 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 62.06897, 37.93103 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 93.10345, 6.896552 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 88.88889, 11.11111 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 77.77778, 22.22222 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 36.66667, 63.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       60,       40 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 93.33333, 6.666667 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 47.36842, 52.63158 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 73.68421, 26.31579 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 89.47368, 10.52632 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 41.93548, 58.06452 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 61.29032, 38.70968 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 93.54839, 6.451613 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 8.262108, 3.133903, 7.122507, 6.267806, 5.128205, 5.982906, 9.116809, 7.122507, 5.698006, 8.547009, 8.262108, 2.564103, 8.547009, 5.413105, 8.831909 ],
"weight": 0.6267857,
"backgroundColor": [ "#a6cee3", "#1f78b4", "#ccebc5", "#fb9a99", "#d95f02", "#fdbf6f", "#e7298a", "#e78ac3", "#ff7f00", "#e41a1c", "#b15928", "#8dd3c7", "#bebada", "#b3de69", "#fccde5" ] 
},
"Intermediate": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Amoxycillin clavulanate": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 71.42857, 28.57143 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 71.42857, 28.57143 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftaroline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Imipenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       40,       60 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       40,       60 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 4.761905, 33.33333, 4.761905, 4.761905,  9.52381, 4.761905, 4.761905, 23.80952,  9.52381 ],
"weight":   0.0375,
"backgroundColor": [ "#a6cee3", "#1f78b4", "#fb9a99", "#d95f02", "#fdbf6f", "#ff7f00", "#b15928", "#b3de69", "#fccde5" ] 
},
"Resistant": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       40,       60 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       20,       80 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Amoxycillin clavulanate": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 23.52941, 76.47059 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 29.41176, 70.58824 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ampicillin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 37.14286, 62.85714 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 54.28571, 45.71429 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine", "Respiratory: Sputum" ],
"percentage": [ 94.28571, 5.714286 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Aztreonam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       20,       80 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       40,       60 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       25,       75 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 41.66667, 58.33333 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftaroline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       25,       75 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [    31.25,    68.75 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       25,       75 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 33.33333, 66.66667 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime avibactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftolozane tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       20,       80 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       40,       60 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 21.42857, 78.57143 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 35.71429, 64.28571 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Doripenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       40,       60 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       20,       80 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Imipenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       40,       60 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       20,       80 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 26.92308, 73.07692 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 42.30769, 57.69231 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       40,       60 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       20,       80 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 18.18182, 81.81818 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 27.27273, 72.72727 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Male" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 2.659574, 9.042553, 18.61702, 5.319149, 6.382979, 8.510638, 6.382979, 1.595745, 5.319149, 7.446809, 2.659574, 2.659574, 13.82979, 2.659574, 5.851064,  1.06383 ],
"weight": 0.3357143,
"backgroundColor": [ "#a6cee3", "#1f78b4", "#b2df8a", "#ccebc5", "#fb9a99", "#d95f02", "#fdbf6f", "#e7298a", "#e78ac3", "#ff7f00", "#e41a1c", "#b15928", "#8dd3c7", "#bebada", "#b3de69", "#fccde5" ] 
} 
}
